PRGO - PERRIGO Co plc
11.69
0.300 2.566%
Share volume: 3,346,507
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$11.39
0.30
0.03%
View ratios
| Fiscal Date | 03-30-2024 | 06-29-2024 | 09-28-2024 | 12-31-2024 | 03-29-2025 | 06-28-2025 | 09-27-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-02-2024 | 11-06-2024 | 02-28-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 10.640 B | 10.397 B | 11.203 B | 9.648 B | 9.760 B | 10.094 B | 10.084 B | 8.535 B | |
| Current Assets | 2.806 B | 2.959 B | 3.708 B | 2.482 B | 2.533 B | 2.615 B | 2.879 B | 2.797 B | |
| Inventories | 1.121 B | 1.116 B | 1.134 B | 1.082 B | 1.155 B | 1.216 B | 1.227 B | 1.149 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 658.500 M | 542.800 M | 1.464 B | 0.000 | 409.900 M | 454.200 M | 432.100 M | 531.600 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 911.400 M | 909.900 M | 909.100 M | 917.800 M | 913.200 M | 913.900 M | 902.800 M | 898.700 M | |
| Other Assets | 6.923 B | 6.528 B | 6.586 B | 6.248 B | 6.314 B | 6.565 B | 6.302 B | 4.839 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.640 B | 10.397 B | 11.203 B | 9.648 B | 9.760 B | 10.094 B | 10.084 B | 8.535 B | |
| Total liabilities | 5.953 B | 5.852 B | 6.637 B | 5.328 B | 5.396 B | 5.622 B | 5.638 B | 5.600 B | |
| Total current liabilities | 1.555 B | 1.488 B | 1.451 B | 1.044 B | 1.074 B | 1.126 B | 1.145 B | 1.013 B | |
| Accounts Payable | 453.700 M | 471.500 M | 458.500 M | 495.200 M | 502.300 M | 489.000 M | 469.700 M | 474.500 M | |
| Other liabilities | 526.200 M | 535.400 M | 660.300 M | 499.200 M | 541.500 M | 673.400 M | 689.700 M | 814.300 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.625 B | 3.617 B | 4.313 B | 3.582 B | 3.591 B | 3.616 B | 3.608 B | 3.604 B | |
| Other liabilities | 526.200 M | 535.400 M | 660.300 M | 499.200 M | 541.500 M | 673.400 M | 689.700 M | 814.300 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.687 B | 4.545 B | 4.566 B | 4.319 B | 4.364 B | 4.472 B | 4.447 B | 2.936 B | |
| Common stock | 6.803 B | 6.786 B | 6.764 B | 6.734 B | 6.693 B | 6.664 B | 6.636 B | 6.608 B | |
| Retained earnings | -2.078 B | -2.187 B | -2.208 B | -2.252 B | -2.259 B | -2.267 B | -2.259 B | -3.678 B |